Skip to main content
. 2015 Nov 9;11(1):299–305. doi: 10.3892/ol.2015.3894

Table I.

Patient characteristics according to the expression of ERCC1, BRCA1, RRM1 and TUBB3.

ERCC1 expression BRCA1 expression RRM1 expression TUBB3 expression




Characteristics Total, n (%) + P-value + P-value + P-value + P-value
NSCLC patients   84 (100) 38 46 73 11 11 73 8 76
Gender
  Female 27 (32) 12 15 0.92 23   4 1.00   4 23 1.00 3 24 1.00
  Male 57 (68) 26 31 50   7   7 50 5 52
Age
  ≤60 66 (79) 33 33 0.09 56 10 0.50   8 58 0.91 6 60 1.00
  >60 18 (21)   5 13 17   1   3 15 2 16
Smoking status
  Smoker 52 (62) 22 30 0.49 44   8 0.65   7 45 1.00 5 47 1.00
  Non-smoker 32 (38) 16 16 29   3   4 28 3 29
Alcohol Intake
  Yes 6 (7)   2   4 0.86   6   0   1.00a   0   6   1.00a 0   6   1.00a
  No 78 (93) 36 42 67 11 11 67 8 70
Histology
  Adenocarcinoma 53 (63) 23 30 0.67 45   8 0.76   8 45 0.76 2 51 0.03
  Squamous cell carcinoma 22 (26) 12 10 20   2   2 20 3 19
  Others   9 (11)   4   5   8   1   1   8 3   6
Stage
  II 36 (43) 16 20 0.90 34   2 0.15   6 30 0.60 4 32 1.00
  IIIa 48 (57) 22 26 39   9   6 42 4 41

P-values were calculated using Pearson's χ2 test.

a

Calculated using Fisher's exact probablility. -, no expression; +, expression; NSCLC, non-small cell lung cancer; ERCC1, excision repair cross-complementation group 1; BRCA1, breast cancer 1; RRM1 ribonucleotide reductase M1; TUBB3, class III β-tubulin.